Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
4.267
-0.023 (-0.54%)
Jul 11, 2025, 9:31 AM - Market open
CDIO Revenue
Cardio Diagnostics Holdings had revenue of $940.00 in the quarter ending March 31, 2025, a decrease of -94.10%. This brings the company's revenue in the last twelve months to $19.90K, down -39.68% year-over-year. In the year 2024, Cardio Diagnostics Holdings had annual revenue of $34.89K with 104.45% growth.
Revenue (ttm)
$19.90K
Revenue Growth
-39.68%
P/S Ratio
246.24
Revenue / Employee
$1,327
Employees
15
Market Cap
7.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34.89K | 17.83K | 104.45% |
Dec 31, 2023 | 17.07K | 16.12K | 1,696.32% |
Dec 31, 2022 | 950.00 | 49.00 | 5.44% |
Dec 31, 2021 | 901.00 | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CDIO News
- 3 days ago - Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease - Business Wire
- 4 weeks ago - Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology - Business Wire
- 6 weeks ago - Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price - Business Wire
- 7 weeks ago - Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico - Business Wire
- 2 months ago - Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split - Business Wire
- 3 months ago - Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session - Business Wire
- 5 months ago - Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations - Business Wire
- 7 months ago - Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - Business Wire